DI-UMONS : Dépôt institutionnel de l’université de Mons

Recherche transversale
Rechercher
(titres de publication, de périodique et noms de colloque inclus)
2007-12-01 - Article/Dans un journal avec peer-review - Anglais - 5 page(s)

Bomati Miguel O., Gossuin Yves , Morales M.P., Gillis Pierre , Muller Robert , Veintemillas-Verdaguer S., "Comparative analysis of the 1H NMR relaxation enhancement produced by iron oxide and core-shell iron–iron oxide nanoparticles" in Magnetic Resonance Imaging, 25, Issue 10, 1437-1441

  • Edition : Elsevier Science, New York (NY)
  • Codes CREF : Physico-chimie générale (DI1320), Biophysique (DI3113), Chimie des colloïdes (DI1329), Imagerie médicale, radiologie, tomographie (DI3243)
  • Unités de recherche UMONS : Physique expérimentale et biologique (M104), Chimie générale, organique et biomédicale (M108)
Texte intégral :

Abstract(s) :

(Anglais) Physicochemical and magnetorelaxometric characterization of the colloidal suspensions consisting of Fe-based nanoparticles coated with dextran have been carried out. Iron oxide and iron core/iron oxide shell nanoparticles were obtained by laser-induced pyrolysis of Fe(CO)5 vapours. Under different magnetic field strengths, the colloidal suspension formed by iron oxide nanoparticles showed longitudinal (R1) and transverse (R2) nuclear magnetic relaxation suspension (NMRD) profiles, similar to those previously reported for other commercial magnetic resonance imaging (MRI) contrast agents. However, colloidal suspension formed by ferromagnetic iron-core nanoparticles showed a strong increase of the R1 values at low applied magnetic fields and a strong increase of the R2 measured at high applied magnetic field. This behaviour was explained considering the larger magnetic aggregate size and saturation magnetization values measured for this sample, 92 nm and 31 emu/g Fe, respectively, with respect to those measured for the colloidal suspensions of iron oxide nanoparticles (61 nm and 23 emu/g Fe). This suspension can be used both as T1 and T2 contrast agent.

Identifiants :
  • PMID : 17566686
  • DOI : 10.1016/j.mri.2007.04.006